Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating safety and efficacy of three regimens—Sodium Stibogluconate with AmBisome, Miltefosine with AmBisome, and Miltefosine alone—fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Miltefosine (miltefosine)
• Sodium Stibogluconate (SSG) (sodium stibogluconate)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Primary Visceral Leishmaniasis | Phase 2 | Status: COMPLETED